26
Participants
Start Date
September 11, 2015
Primary Completion Date
July 31, 2018
Study Completion Date
December 24, 2024
Palbociclib
125 mg orally once daily with food on Day 1 to Day 21 followed by 7 days off treatment in a 28-day cycle
Letrozole
2.5 mg , orally once daily (continuously)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Beijing Cancer Hospital/Oncology department, Beijing
The first hospital of jilin university, Changchun
Harbin Medical University Cancer Hospital, Harbin
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
Sun Yat-Sen University Cancer Center, Guangzhou
Guangdong General Hospital/Department of Breast Surgery, Guangzhou
Lead Sponsor
Pfizer
INDUSTRY